121 related articles for article (PubMed ID: 7046248)
1. Immune Unresponsiveness to platelets. A case study.
Pegels JG; Bruynes EC; Korthals Altes HR; Engelfriet CP; von dem Borne AE
Vox Sang; 1982; 42(4):211-6. PubMed ID: 7046248
[TBL] [Abstract][Full Text] [Related]
2. [Experience of HLA-matched platelet transfusion in patients who are refractory to random donor platelets].
Sekiguchi S; Mitani T; Ohnuma M; Katoh T; Ikeda H; Nakase T; Morioka M; Sakurada K; Miyazaki T
Hokkaido Igaku Zasshi; 1988 Jul; 63(4):552-61. PubMed ID: 3220437
[TBL] [Abstract][Full Text] [Related]
3. Management of patients with hematologic malignancies and aplastic anemia who are refractory to platelet transfusions.
Sandler SG
Haematologia (Budap); 1998; 29(1):1-11. PubMed ID: 9704252
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing platelet survival during antilymphocyte globulin treatment.
Gratama JW; Brand A; Jansen J; Zwaan FE; Valentijn RM; Eernisse JG
Br J Haematol; 1984 May; 57(1):5-15. PubMed ID: 6722037
[TBL] [Abstract][Full Text] [Related]
5. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
[TBL] [Abstract][Full Text] [Related]
6. [HLA compatibility and survival of 51 chromium-labeled allogeneic thrombocytes].
Májský A; Fortýnová J; Vopatová M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):831-7. PubMed ID: 6176508
[TBL] [Abstract][Full Text] [Related]
7. Refractoriness to random donor platelet transfusions in patients with aplastic anaemia: a multivariate analysis of data from 264 cases.
Klingemann HG; Self S; Banaji M; Deeg HJ; Doney K; Slichter SJ; Thomas ED; Storb R
Br J Haematol; 1987 May; 66(1):115-21. PubMed ID: 3593647
[TBL] [Abstract][Full Text] [Related]
8. [Aplastic anemia with antiplatelet iso-antibody and intracerebral hemorrhage--a case report of a child treated by platelet transfusion, splenectomy and craniotomy (author's transl)].
Fukazawa K; Nagao T; Kuwana N; Pak S; Juji T; Shibata Y
Rinsho Ketsueki; 1980 Nov; 21(11):1761-6. PubMed ID: 7206230
[No Abstract] [Full Text] [Related]
9. How much residual plasma may cause TRALI?
Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
[TBL] [Abstract][Full Text] [Related]
10. Tolerance induction in a fully allogeneic combination using anti-T cell receptor-alpha beta monoclonal antibody, low dose irradiation, and donor bone marrow transfusion.
Nomoto K; Yung-Yun K; Omoto K; Umesue M; Murakami Y; Matsuzaki G; Nomoto K
Transplantation; 1995 Feb; 59(3):395-401. PubMed ID: 7871570
[TBL] [Abstract][Full Text] [Related]
11. An alloimmunized, thrombocytopenic patient successfully transfused with acid-treated, random-donor platelets.
Shanwell A; Sallander S; Olsson I; Gulliksson H; Pedajas I; Lerner R
Br J Haematol; 1991 Nov; 79(3):462-5. PubMed ID: 1751374
[TBL] [Abstract][Full Text] [Related]
12. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components.
Eernisse JG; Brand A
Exp Hematol; 1981 Jan; 9(1):77-83. PubMed ID: 7238644
[TBL] [Abstract][Full Text] [Related]
13. Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function.
Leech SH; Mather PJ; Eisen HJ; Pina IL; Margulies KB; Bove AA; Jeevanandam V
Clin Transplant; 1996 Dec; 10(6 Pt 2):639-45. PubMed ID: 8996758
[TBL] [Abstract][Full Text] [Related]
14. Induction of operational tolerance by random blood transfusion combined with anti-CD4 antibody therapy. A protocol with significant clinical potential.
Bushell A; Morris PJ; Wood KJ
Transplantation; 1994 Jul; 58(2):133-9. PubMed ID: 8042231
[TBL] [Abstract][Full Text] [Related]
15. Platelet crossmatch testing for donor selection.
Slichter SJ
Prog Clin Biol Res; 1982; 88():153-64. PubMed ID: 7100207
[TBL] [Abstract][Full Text] [Related]
16. Platelet survival test. A method to detect preimmunization in rabbits.
Andersen OS; Tissot RG; Cohen C; Jonasson O
Transplantation; 1973 Jan; 15(1):101-10. PubMed ID: 4575915
[No Abstract] [Full Text] [Related]
17. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T
J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720
[TBL] [Abstract][Full Text] [Related]
18. Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells.
Bacchetta R; Vandekerckhove BA; Touraine JL; Bigler M; Martino S; Gebuhrer L; de Vries JE; Spits H; Roncarolo MG
J Clin Invest; 1993 Mar; 91(3):1067-78. PubMed ID: 8450037
[TBL] [Abstract][Full Text] [Related]
19. Platelet-induced donor-specific unresponsiveness to kidney allografts in mongrel dogs treated with ALG.
Rowinski W; Ryffa T; Ruke M; Wasowska B; Tilney NL; Olszewski WL
Transplant Proc; 1981 Mar; 13(1 Pt 1):586-8. PubMed ID: 6168052
[No Abstract] [Full Text] [Related]
20. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
